Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Lymphoma
- Brain and Spinal Cord Cancer
- Radiation Oncology
- Gastrointestinal Cancer
- Hematology
- Kidney Cancer
- Central Nervous System Tumors
- Melanoma/Skin Cancer
Abstract
Citation: Clin Oncol. 2017;2(1):1266.DOI: 10.25107/2474-1663.1266
Acute Esophageal Necrosis Complicated by Severe Upper Gastrointestinal Bleeding in Association with Bosutinib Treatment for Chronic Myelogenous Leukemia
Danah Mohammad, Anwar Albasri, Jeff Lipton and Michael Beyak
Department of Medicine, Queens University, Kingston, ON, Canada
Department of Medical Oncology and Hematology, University of Toronto, Toronto, Canada
*Correspondance to: Jeff Lipton
PDF Full Text Case Report | Open Access
Abstract:
Acute Esophageal Necrosis (AEN), also known as “Black Esophagus”, is a rare life threatening condition with unknown cause. We present a case of AEN in an 82 years-old male on Tyrosine Kinase Inhibitor (TKI) for Chronic Myelogenous Leukemia (CML). While TKI is known to cause GI toxicity, this is the first case, to our knowledge, reporting AEN.
Keywords:
Cite the Article:
Mohammad D, Albasri A, Lipton J, Beyak M. Acute Esophageal Necrosis Complicated by Severe Upper Gastrointestinal Bleeding in Association with Bosutinib Treatment for Chronic Myelogenous Leukemia. Clin Oncol. 2017; 2: 1266.